Taghap, Baby Boy S.
HRN: 22-34-19 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2022
AMPICILLIN 250MG (VIAL)
12/15/2022
12/22/2022
IVT
115 Mg
12 Hrs
T/c Neonatal Asphyxia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes